Lapinsky Exam 3 Antibiotic Summary

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/91

encourage image

There's no tags or description

Looks like no tags are added yet.

92 Terms

1
New cards

Describe the mechanism of action of vancomycin

Binds D-Ala-D-Ala and inhibits bacterial cell wall synthesis

2
New cards

Identify the primary antimicrobial coverage of vancomycin

Gram-positive organisms, including MRSA

3
New cards

Describe the use of oral vancomycin

Treatment of C. difficile infection

4
New cards

Identify the major adverse effects of vancomycin

- Nephrotoxicity

- Infusion reactions (Red Man Syndrome)

5
New cards

Describe the mechanism of action of Bactrim (TMP-SMX)

- Sequentially inhibits folate synthesis

- SMX inhibits DHPS

- TMP inhibits DHFR

6
New cards

Identify the primary clinical uses of Bactrim

UTIs, susceptible community-acquired MRSA, and Pneumocystis jirovecii

7
New cards

Identify the major adverse effects of Bactrim

- Hyperkalemia (TMP)

- Bone marrow suppression (TMP)

- SJS/TEN (SMX)

8
New cards

Describe the mechanism of action of fluoroquinolones

Inhibit DNA gyrase (topoisomerase II) and topoisomerase IV

9
New cards

Identify the primary antimicrobial coverage of fluoroquinolones

Gram-negative infections and selected respiratory infections

10
New cards

Identify the major adverse effects of fluoroquinolones

Tendinopathy/rupture, peripheral neuropathy, CNS effects, and QT prolongation

11
New cards

Describe the mechanism of action of aminoglycosides

Irreversibly bind the 30S ribosomal subunit, causing mRNA misreading

12
New cards

Identify the primary antimicrobial coverage of aminoglycosides

Serious aerobic Gram-negative infections and synergistic use in selected infections

13
New cards

Identify the major adverse effects of aminoglycosides

- Nephrotoxicity

- Ototoxicity

- Neuromuscular blockade

14
New cards

Describe the mechanism of action of tetracyclines

Reversibly bind the 30S ribosomal subunit and block aminoacyl-tRNA binding

15
New cards

Identify the primary clinical uses of tetracyclines

Atypical infections, tick-borne infections, acne, and susceptible MRSA

16
New cards

Identify the major adverse effects of tetracyclines

- Photosensitivity

- Esophagitis

- Tooth discoloration

17
New cards

Describe the mechanism of action of macrolides

Bind the 50S ribosomal subunit and inhibit translocation

18
New cards

Identify the primary clinical uses of macrolides

Respiratory infections, atypical pathogens, and pertussis

19
New cards

Identify the major adverse effects of macrolides

GI effects, QT prolongation, and drug interactions

20
New cards

Describe the mechanism of action of linezolid

Binds the 50S ribosomal subunit and prevents formation of the initiation complex

21
New cards

Identify the primary antimicrobial coverage of linezolid

MRSA, VRE, and resistant Gram-positive infections

22
New cards

Identify the major adverse effects of linezolid

- Thrombocytopenia

- Serotonin syndrome

- Neuropathy

23
New cards

Describe the mechanism of action of clindamycin

Binds the 50S ribosomal subunit and inhibits bacterial protein synthesis

24
New cards

Identify the primary antimicrobial coverage of clindamycin

Anaerobes (especially above the diaphragm) and selected Gram-positive infections

25
New cards

Identify the major adverse effects of clindamycin

C. difficile infection and diarrhea

26
New cards

Describe the pharmaceutical properties of vancomycin

Large, polar glycopeptide that is poorly absorbed orally

27
New cards

Describe why vancomycin is given IV for systemic infections

Poor oral absorption prevents adequate systemic drug levels

28
New cards

Describe the use of oral vancomycin

Treats intestinal C. difficile infections because it remains in the GI tract

29
New cards

Describe the pharmaceutical mechanism of Bactrim

TMP and SMX inhibit consecutive steps in bacterial folate synthesis, producing synergistic antibacterial activity

30
New cards

Describe why trimethoprim (TMP) can cause hyperkalemia

Inhibits renal epithelial sodium channels (ENaC), reducing potassium excretion

31
New cards

Describe the interaction between fluoroquinolones and metal cations

Fluoroquinolones chelate calcium, magnesium, aluminum, and iron

32
New cards

Describe how metal cations affect fluoroquinolone absorption

Chelation decreases oral absorption

33
New cards

Describe the pharmaceutical properties of aminoglycosides

Highly polar, polycationic molecules

34
New cards

Describe how aminoglycoside polarity affects drug absorption and distribution

Poor oral absorption and poor CNS penetration

35
New cards

Identify the primary route of elimination for aminoglycosides

Renal elimination

36
New cards

Describe the interaction between tetracyclines and metal cations

Tetracyclines chelate polyvalent metal cations

37
New cards

Identify substances that decrease tetracycline absorption

Antacids, iron supplements, and certain dairy products

38
New cards

Describe the pharmaceutical properties of macrolides

Weak bases that accumulate intracellularly

39
New cards

Describe why macrolides are useful against intracellular pathogens

Their ability to accumulate inside cells improves activity against intracellular bacteria

40
New cards

Identify macrolides that inhibit CYP3A4

Erythromycin and clarithromycin

41
New cards

Describe linezolid's effect on monoamine oxidase (MAO)

Reversibly inhibits MAO

42
New cards

Describe why linezolid increases the risk of serotonin syndrome

MAO inhibition increases serotonin activity when combined with serotonergic medications

43
New cards

Describe clindamycin's activity against intestinal bacteria

Strong activity against susceptible anaerobic gut flora

44
New cards

Describe why clindamycin increases the risk of C. difficile infection

Disrupts normal intestinal microbiota, allowing C. difficile to overgrow

45
New cards

Describe the antimicrobial coverage of ciprofloxacin

Strong Gram-negative activity, including Pseudomonas, but weak pneumococcal coverage

46
New cards

Describe the antimicrobial coverage of levofloxacin

Respiratory fluoroquinolone that covers S. pneumoniae and Pseudomonas

47
New cards

Describe the antimicrobial coverage of moxifloxacin

Respiratory pathogens and anaerobic bacteria

48
New cards

Describe why moxifloxacin is not appropriate for UTIs

It does not achieve adequate urinary concentrations

49
New cards

Describe the distinguishing characteristics of ofloxacin

An older fluoroquinolone available in systemic, ophthalmic, and otic formulations

50
New cards

Describe the primary clinical uses of gentamicin

Serious Gram-negative infections and selected synergistic regimens

51
New cards

Describe the antimicrobial coverage of tobramycin

Particularly useful against Pseudomonas

52
New cards

Identify the use of inhaled tobramycin

Treatment of chronic pulmonary infections

53
New cards

Describe the distinguishing characteristic of amikacin

Often remains active against some gentamicin- and tobramycin-resistant organisms

54
New cards

Describe the distinguishing characteristics of tetracycline

- Greater food and cation absorption concerns

- Primarily eliminated by the kidneys

55
New cards

Describe the distinguishing characteristics of doxycycline

Excellent oral bioavailability and minimal dependence on renal clearance

56
New cards

Describe the distinguishing characteristics of minocycline

More lipophilic and associated with vestibular adverse effects and pigmentation

57
New cards

Describe the distinguishing characteristics of azithromycin

Long tissue persistence and relatively few CYP450 drug interactions

58
New cards

Describe the distinguishing characteristics of clarithromycin

Strong CYP3A4 inhibitor with an active metabolite

59
New cards

Describe the distinguishing characteristics of erythromycin

Strong CYP3A4 inhibitor with pronounced GI adverse effects

60
New cards

Describe why erythromycin causes significant GI adverse effects

Stimulates motilin receptors, increasing GI motility

61
New cards

Identify the antibiotic class associated with tendon pain and rupture

Fluoroquinolones

62
New cards

Identify the antibiotic class associated with hearing loss

Aminoglycosides (ototoxicity)

63
New cards

Identify the antibiotic associated with hyperkalemia

Bactrim (TMP-SMX)

64
New cards

Describe how Bactrim causes hyperkalemia

Trimethoprim inhibits renal epithelial sodium channels (ENaC), reducing potassium excretion

65
New cards

Identify the antibiotic associated with severe diarrhea and C. difficile infection

Clindamycin

66
New cards

Describe why clindamycin increases the risk of C. difficile infection

This drug disrupts normal intestinal microbiota, allowing C. difficile overgrowth

67
New cards

Identify the antibiotic associated with serotonin syndrome when combined with SSRIs

Linezolid

68
New cards

Describe why linezolid increases the risk of serotonin syndrome

This drug reversibly inhibits monoamine oxidase (MAO), increasing serotonin activity

69
New cards

Identify the antibiotic classes with decreased absorption when taken with iron supplements

- Tetracyclines

- Fluoroquinolones

70
New cards

Describe why iron supplements decrease antibiotic absorption

Metal-ion chelation reduces antibiotic absorption

71
New cards

Identify the antibiotic classes associated with photosensitivity

- Tetracyclines

- Fluoroquinolones

72
New cards

Identify the antibiotic associated with infusion-related flushing

IV vancomycin

73
New cards

Describe why IV vancomycin causes infusion-related flushing

- Rate-dependent histamine release

- Fast IV infusion triggers histamine release, which widens blood vessels and reddens the skin

74
New cards

Identify the macrolides associated with statin drug interactions

- Clarithromycin

- Erythromycin

75
New cards

Describe why clarithromycin and erythromycin interact with certain statins

CYP3A4 inhibition increases concentrations of CYP3A4-metabolized statins, increasing possible muscle toxicity

76
New cards

Describe why oral vancomycin treats intestinal infections but not systemic infections

Poor oral absorption keeps vancomycin primarily in the intestines

77
New cards

Define bactericidal antibiotics

Antibiotics that kill bacteria

78
New cards

Define bacteriostatic antibiotics

Antibiotics that inhibit bacterial growth and reproduction

79
New cards

Identify the primarily bactericidal antibiotics

- Vancomycin

- Bactrim (organism-dependent)

- Fluoroquinolones

- Aminoglycosides

80
New cards

Identify the primarily bacteriostatic antibiotics

- Tetracyclines

- Macrolides

- Linezolid

- Clindamycin

81
New cards

Identify the primary molecular targets of antibiotics

- Bacterial cell wall

- DNA synthesis

- Ribosomes (protein synthesis)

82
New cards

Identify the antibiotic classes that target the 30S ribosomal subunit

- Aminoglycosides

- Tetracyclines

83
New cards

Identify the antibiotics that target the 50S ribosomal subunit

- Macrolides

- Linezolid

- Clindamycin

84
New cards

Describe why vancomycin and aminoglycosides have poor oral absorption

Their molecular properties make them poorly absorbed through the GI tract

85
New cards

Identify the antibiotic classes that chelate metal cations

- Tetracyclines

- Fluoroquinolones

86
New cards

Identify the antibiotic associated with hyperkalemia

Trimethoprim (Bactrim)

87
New cards

Identify the antibiotic that inhibits monoamine oxidase (MAO)

Linezolid

88
New cards

Identify the macrolides associated with CYP3A4 inhibition

- Clarithromycin

- Erythromycin

89
New cards

Identify the major toxicities associated with aminoglycosides

- Ototoxicity (ears)

- Nephrotoxicity (kidneys)

90
New cards

Identify the major toxicity associated with fluoroquinolones

Tendinitis and tendon rupture

91
New cards

Identify the major infection risk associated with clindamycin

C. difficile infection

92
New cards

Identify the major hematologic adverse effect associated with linezolid

Thrombocytopenia (decreased platelets)